BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6684466)

  • 1. High-resolution autoradiography in mouse brain 24 h after radiolabelled CDP-choline administration.
    Romero A; Serratosa J; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1056-8. PubMed ID: 6684466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution autoradiography in mouse brain and cerebellum 10 days after radiolabelled CDP-choline administration.
    Romero A; Serratosa J; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1058-60. PubMed ID: 6684467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-resolution autoradiography in rat brain after administering labelled CDP-choline.
    Romero A; Serratosa J; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1054-6. PubMed ID: 6684465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral subcellular distribution of CDP-choline and/or its metabolites after oral administration of methyl-14C CDP-choline.
    Aguilar J; Giménez R; Bachs O; Enrich C; Agut J
    Arzneimittelforschung; 1983; 33(7A):1051-3. PubMed ID: 6225438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioactivity incorporation into different cerebral phospholipids after oral administration of 14C methyl CDP-choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1048-50. PubMed ID: 6684464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of methyl-14C CDP-choline by oral route.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1045-7. PubMed ID: 6684463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the intrathecal pharmacotherapy. Part I: CDP-choline.
    Ogashiwa M; Takeuchi K; Hara M; Tanaka Y; Okada J
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):327-35. PubMed ID: 1242132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1016-8. PubMed ID: 6684453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of 14C CDP-choline.
    Dinsdale JR; Griffiths GK; Rowlands C; Castelló J; Ortiz JA; Maddock J; Aylward M
    Arzneimittelforschung; 1983; 33(7A):1066-70. PubMed ID: 6412727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDP-choline: acute toxicity study.
    Grau T; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1033-4. PubMed ID: 6684459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cytidine-diphosphate choline (CDP-choline) on brain lipid changes during aging.
    De Medio GE; Trovarelli G; Piccinin GL; Porcellati G
    J Neurosci Res; 1984; 11(1):49-58. PubMed ID: 6708133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the protection of CDP-choline against nicotine intoxication.
    Grau T; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1025-6. PubMed ID: 6684456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytidine diphosphate choline (citicoline, Somazina).
    Arzneimittelforschung; 1983; 33(7A):1011-80. PubMed ID: 6684451
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1026-9. PubMed ID: 6684457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the effects of oral administration of CDP-choline on EEG changes and lethality induced by epidural compression in the anaesthetised cat.
    Algate DR; Beard DJ; Sacristán A; Ortiz JA; Davies JE
    Arzneimittelforschung; 1983; 33(7A):1013-6. PubMed ID: 6684452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of CDP-choline in phospholipid metabolism of brain tissue in vitro.
    Arienti G; Corazzi L; Mastrofini P; Montanini I; Tirillini B; Porcellati G
    Ital J Biochem; 1979; 28(1):39-45. PubMed ID: 553079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of subacute toxicity of CDP-choline after 30 days of oral administration to rats.
    Romero A; Grau T; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1035-8. PubMed ID: 6684460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDP-choline: 6-month study on toxicity in dogs.
    Romero A; Grau T; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1038-42. PubMed ID: 6684461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral CDP-choline on acrylamide-induced lesion.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1029-33. PubMed ID: 6684458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.